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Abstract
Background: The presence of chemicals in the environment is ubiquitous. Human biomonitoring studies have
shown that various chemicals can be detected in the majority of the population, including pregnant women.
These compounds may pass the placenta, and reach the fetus. This early life exposure in particular may be
detrimental as some chemicals may disrupt the endocrine system, which is involved in various processes during
development. The LINC study is a prospective birth cohort designed to study associations between early life
environmental exposures and child health, including growth and neurodevelopment. The purpose of this
paper is to give an overview of this cohort.
Methods and design: Recruitment for this cohort has started in 2011 in three Dutch areas and is still ongoing. To
date over 300 mother-child pairs have been included. Women are preferably included during the first trimester of
pregnancy. Major congenital anomalies and twin births are reasons for exclusion. To assess exposure to environmental
chemicals, cord blood, placenta, meconium and vernix are collected. Parents collect urine of the child shortly after birth
and breast milk in the second month of life. Exposure to a broad range of environmental chemicals are determined in
cord plasma and breast milk. Furthermore various hormones, including leptin and cortisone, are determined in cord
plasma, and in heel prick blood spots (thyroxine). Data on anthropometry of the child is collected through midwives
and youth health care centres on various time points until the child is 18 months of age. Furthermore
cognitive development is monitored by means of the van Wiechen scheme, and information on behavioral
development is collected by means of the infant behavior questionnaire and the child behavior checklist.
When the child is 12 months of age, a house visit is scheduled to assess various housing characteristics, as
well as hand-to-mouth behavior of the child. At this visit exposure of the child to flame retardants (with
endocrine disrupting properties) in house dust is determined by means of body wipes. They are furthermore
also measured in a saliva sample of the child. Next to these measurements, women receive questionnaires
each trimester regarding amongst others lifestyle of the parents, general health of the parents and the child,
and mental state of the mother.
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Discussion: This study was approved by the medical ethics committee of the VU University Medical Centre.
Consent for the infant is given by the mother, who is specifically required to give consent for both herself as
well as her child. Results will be published regardless of the findings of this study, and will be widely disseminated
among related medical stakeholders (e.g. midwives and pediatricians), policy makers, and the general public.
Keywords: Endocrine disrupting chemicals, Developmental origins of health and disease, Early life exposure, Child
growth, Neurodevelopment
Background
Chemicals are used worldwide, making everyday life
more comfortable. Their integration into modern day
society extends to a level that consumers are often un-
aware of their presence. They are incorporated in com-
mon items, e.g. food packaging materials containing
bisphenol a (BPA) and phthalates, which may transfer
from the packaging material to the food item itself [1].
Furthermore food products and water may contain pes-
ticides, including those banned from production but per-
sistent in the environment [2]. This ubiquitous presence
of chemicals inevitably results in human exposure.
Human biomonitoring studies in the United States de-
tected several chemicals such as perfluorinated alkyl
acids (PFAAs) and polychlorinated biphenyls (PCBs) in
90–100 % of the population [3], including pregnant
women [4]. They have also been quantified in amniotic
fluid [5, 6] and cord blood [7, 8], which indicates that
they may pass the placenta and reach the foetus. As the
presence of contaminants has also been established in
breast milk [9], it is clear that exposure not only starts
prenatally, it also continues in early life.
Research has shown that certain compounds may
interfere with the function of hormones (endocrine dis-
rupting chemicals, EDCs), including thyroid hormones,
estrogen, and testosterone (reviewed by Bergman et al.
[10]), which are involved in various processes in adults,
but also in brain development early in life [11, 12]. They
may also interact with peroxisome proliferator activated
receptor α and γ, involved in amongst others adipo-
genesis [10]. Furthermore, exposure early in life may
cause epigenetic modifications, resulting in increased
expression or silencing of genes - effects which may
be trans-generational [13]. Another point to consider
is that exposure early in life may have different effects
than exposure in adulthood, as developmental plasti-
city is much higher in the first period of life [14].
An increasing number of children nowadays face the
diagnosis of diabetes type 2 [15], obesity [16, 17], atten-
tion deficit hyperactivity disorder [18], autism spectrum
disorder [19], and other behavioral disorders. Even
though increased risks for each of these health problems
have been observed with increased exposure to chemi-
cals [20–22], results are not unambiguous and variations
in methodology complicate comparison between different
studies. Furthermore, the focus in most observational re-
search has been on non-dioxin-like PCBs and dichlorodi-
phenyldichloroethylene (DDE), while other compounds
such as perfluorinated alkyl acids, and phthalates have
been identified as potential health threats as well, but have
not yet been investigated as thoroughly.
For most non-communicable diseases important risk
factors has been well established, e.g. the role of diet and
physical activity in the etiology of obesity and diabetes
type 2. However, the increasing prevalence of these dis-
eases in children and their impact on society and health
care costs, has created a need to further explore the role
of environmental factors. This has led to calls from the
European Union to motivate research on this particular
topic. As a result, the LInking EDCs in maternal Nu-
trition to Child health (LINC) study has been set up
to investigate health effects of perinatal exposure to a
variety of EDCs, and to study determinants of exposure,
including parental lifestyle, maternal dietary intake, the
residential and occupational environment, and child be-
haviors. The purpose of this paper is to give an overview
of this cohort, for which recruitment has started in 2011,
and is currently still ongoing. Study protocols as they cur-
rently are used will be reported, including future plans for
follow-up. We will furthermore describe the strengths and
limitations of this cohort, as well as its’ potential in light
of current scientific challenges.
Methods
The LINC study is a population-based, prospective birth
cohort study. It has been initiated to study the effects of
perinatal exposure to EDCs on various health outcomes
later in life. The general aims of the study are (Fig. 1):
1. To relate early life exposure markers of EDCs with
effect biomarkers, child health outcome data and
other parameters via multiple regression and
multivariate analysis, while taking into account
relevant confounders and covariates.
2. To determine factors which are relevant for
exposure to EDCs, including, parental lifestyle
factors, maternal diet, factors in the residential and/
or occupational area, and child behavior types.
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Subjects
All children without major congenital anomalies who are
born to women living in the area of Zwolle, Purmerend,
or Den Helder (Fig. 2 [23]) are allowed to participate in
the cohort. The area of Zwolle in particular was chosen
because of the relatively low level of urbanization; about
59 % of the Zwolle city area is used for agriculture.
Purmerend and Den Helder differ substantially from
Zwolle, both from an environmental and demographic
perspective. Purmerend for example is a primarily urban
region, and has a higher percentage of population of non-
western origins compared to Zwolle (15.1 % vs. 10.0 %).
Den Helder on the other hand is characterized by fishery,
and a large naval base. Moreover, there is a relatively high
number of teen pregnancies (between 0.81–1.53 against
0.6 in the general Dutch population). However, these re-
gional differences offer the opportunity to compare results
for different populations.
In the Netherlands, primary care during pregnancy is
given by midwives, with obstetricians only involved in
complicated pregnancies. Furthermore it is not uncom-
mon for deliveries to occur in the home environment:
between 2011 and 2013 approximately 20 % of births
were at home [24]. Pregnant women have therefore been
recruited through midwifery clinics from 2011 and on-
wards. Recruitment started in 2011 in Zwolle, after
which Purmerend and Den Helder were added as loca-
tions. Recruitment in these latter locations is still on-
going, but was finished in Zwolle in 2013. To date over
300 mother-child pairs have been included. Women less
than 12 weeks pregnant at their first visit to the clinic
are preferred for inclusion, however women may also be
included at later stages in pregnancy. They are consid-
ered eligible for participation if they are able to fill out
questionnaires in Dutch. Decisionally incapacitated sub-
jects are not asked to participate, and twin pregnancies
are excluded.
Thus far eight midwifery clinics have been involved in
recruitment. Of these, six are located in the area of
Zwolle. Midwifery clinics are chosen based on the num-
ber of hospitals they cooperate with in the area. If trans-
fer options are limited to one hospital, the clinic is
eligible for participation, as this facilitates tracking of
child births which do not occur in the home situation.
In Zwolle, where recruitment is already finished, about
one in fifteen women agreed to participation.
Follow-up of subjects
Data from regular care provided by midwives and/or ob-
stetricians is collected for information on women’s
health during pregnancy. Further information on the
period before and during pregnancy is collected by
means of questionnaires, which are sent out to women
at inclusion, and at the end of each trimester (4 weeks
after birth for the last trimester). Follow-up of the child
is done by youth healthcare organizations (at 1, 2, 3, 4,
6, 9, 12, and 18 months of age, according to standard-
ized protocols [25]), which monitor growth and develop-
ment of children as part of the Dutch health care
program. Questionnaires are sent to the mothers when
the children are 3, 6, 9, 12, and 18 months of age. Bio-
logical samples are collected at birth and in the first 2
months after birth. Furthermore a house visit is sched-
uled at 12 months of age to make an inventory of the
home environment. An overview of the follow-up is
given in Fig. 3.
Measurements
A complete overview of measurements during pregnancy
and the first 18 months after birth is given in Table 1.
Assessment of exposure
The aim is to assess perinatal exposure. For this purpose
cord blood is collected from each participant at birth.
Fig. 1 Overview of study aims
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Blood samples taken from the mother are not collected
for the study, as women are allowed to enter the study
during any stage of pregnancy. The latest moment of
inclusion is just before birth, therefore this moment is
most suitable to start collection of samples. Next to
that, cord blood is considered a proxy for prenatal ex-
posure and collection is non-invasive for both mother
and child. To determine postnatal exposure, mothers
are instructed to collect breast milk during 1 week,
starting 4 weeks after birth. Use of a breast pump is
allowed, and when used, the brand of the pump is pro-
vided by the participant. Timing of breast milk collec-
tion was decided upon after feedback in a pilot study,
in which mothers indicated that collection any earlier
after birth was uncomfortable. Furthermore, a small
piece from the fetal side of the placenta is collected for
epigenetic studies, as well as a sample of vernix and
meconium. Parents collect a urine sample of the child
during the first week after birth, however we will aim
to collect multiple urine samples of the child during
early childhood. Finally, at 12 months, a saliva sample
of the child is collected.
Exposure to PCB-153, DDE, hexachlorobenzene (HCB),
dioxins (CALUX), brominated diphenyl ether (BDE)-47,
BDE-99, hexabromocyclododecane (HBCD), perfluorooc-
tanesulfonic acid (PFOS), perfluorooctanoic acid (PFOA),
and the secondary DEHP metabolites mono(2-ethyl-5-car-
boxypentyl) phthalate (MECPP), mono(2-ethyl-5-hydroxy-
hexyl) phthalate (MEHHP), and mono(2-ethyl-5-oxohexyl)
phthalate (MEOHP) will be assessed in cord blood and
breast milk. These chemicals will be studied in particular
for their suspected obesogenic health effects [26]. Other
chemicals will include organophosphates, carbamates,
neonicotinoids, pyrethroids, and methylmercury. Some
of these compounds, such as the carbamates and neo-
nicotinoids, have not been studied frequently for their
health effects in humans. As they are suspected neu-
rotoxicants, they will be predominantly studied in
context of child behavioral development. Additionally
levels of resorcinol bis(diphenylphosphate) (RBDPP)
Fig. 2 Population density in the Netherlands 2012
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and bisphenol A bis(diphenylphosphate) (BPA-BDPP)
will be determined in the saliva samples as well as
the indoor dust samples. These two flame retardants
are used as alternatives for deca-BDE in TV or flat
screen housings, as well as other electronic equip-
ment. For standardization purposes, the same labora-
tory is used per compound. Samples which are thus
far not used will be stored for additional analyses,
and more compounds may be determined as the
study progresses. Lab QA/QC procedures have been
published previously [27].
Health outcomes
There are various parameters early in life which are
indicators for development later in life. Birth weight
for example is inversely associated with hypertension
and type 2 diabetes in adulthood [28, 29], and both
high and low birth weight have been associated with
obesity [30, 31]. Rapid growth in infancy has been
identified as an independent risk factor for childhood
obesity [32, 33]. A recent study by Gittner et al.
showed that children who were obese at the age of 5
years already had distinct body mass index (BMI) pat-
terns before 12 months of age, with children who had
a normal BMI at age five always having a lower BMI
from age 6 months and onwards compared to children
who were obese at age 5 years [34]. They furthermore
showed that BMI patterns over time differed between
male and female children. Childhood obesity has also
been related to exposure to endocrine disrupting che-
micals early in life. Several studies have observed
positive associations with BMI for chemicals such as
organochlorine pesticides (e.g. DDE, HCB) [7, 35, 36]
and PFAAs [37], although results are not unambigu-
ous [38, 39].
Also brain development is regulated and influenced
by hormones, and especially thyroid hormones are
known to be essential for normal embryonal and foetal
neurogenesis [40]. EDCs are known to affect thyroid
hormonal function in particular. Therefore disruption
of hormonal function during specific time periods im-
portant for brain development may have many conse-
quences and may amongst others have adverse effects
on neurodevelopment. Positive associations for prenatal
EDC exposure and autism spectrum disorders have
been reported [41–44], however studies in this area are
relatively scarce. For attention deficit hyperactivity dis-
order, study results seem to be more convincing of an
association with early life exposure to endocrine disrup-
tors [20].
Given the physiological processes which may be af-
fected by EDC exposure, it was decided to focus on
physical growth as well as neurodevelopment. These
outcomes are partially monitored by youth health care
centres, which determine child weight, height, waist,
and head circumference, and which monitor cognitive
development by means of the van Wiechen scheme
[45]. Furthermore at 12 months, the Infant Behavior
Questionnaire is administered [46], followed by the
Child Behavior CheckList (CBCL) at 18 months [47].
An overview of data collected from the child regard-
ing physical growth and behavioral development, and
by whom, is given in Table 2.
All measurements are performed by trained and ex-
perienced staff. Furthermore midwives received a meas-
uring tape as well as strict instructions on how to
perform these measurements, including to what preci-
sion measurements should be done (e.g. for birth
weight: to the nearest 10 g). Weighing scales are pro-
vided by the midwife and are calibrated daily. Youth
Fig. 3 Sample collection and follow-up of main health outcomes within the LINC study
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Table 1 Measurements in LINC during pregnancy and the first 18 months after birth







Weight (mother, and father) Maternal diet before
pregnancy (FFQ)
Demographics
Length (mother and father) Occupational and
residential exposure
Previous pregnancies, fertility
Allergies (mother and father)
Lifestyle














Mental state, stress (mother)
Social support (mother)
Birth Cord blood Birth weight






Month 1 Weight and length van Wiechen Scheme
Head circumference
Month 2 Breast milk Weight and length van Wiechen Scheme
Head circumference
Month 3 Weight and length van Wiechen Scheme Infant diet
Head circumference Second hand smoke exposure
Mental state, stress (mother)
Crying/sleeping pattern
Month 4 Weight and length van Wiechen Scheme
Head circumference
Month 6 Weight and length van Wiechen Scheme Occupational and
residential exposure
Infant diet
Head circumference Second hand smoke exposure
Mental state, stress (mother)
Social support (mother)
Crying/sleeping pattern
Month 9 Weight and length van Wiechen Scheme Infant diet
Head circumference Second hand smoke exposure
Mental state, stress (mother)
Crying/sleeping pattern
Month 12 Saliva Weight and length van Wiechen Scheme Hand, back, and mouth
wipe
Infant diet
Head circumference Child behavior (infant
behavior questionnaire)







Mental state, stress (mother)
Crying/sleeping pattern
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health care organizations received similar instructions as
the midwives regarding measurement of weight, length,
waist, and head circumference. Furthermore validated
questionnaires are used to ensure quality of the data.
Determinants of exposure
Exposure to chemicals occurs in part through diet [48].
However, diet is a factor which is relatively easy to con-
trol or change and may therefore be a potential pathway
through which daily exposure can be decreased. This
was for example shown by Rudel et al. [1] who observed
a significant reduction after a ‘fresh food’ intervention,
which implied that participants followed a 3 day diet
containing no canned foods or foods packaged in plastic
[1]. We therefore aim to assess the relevance of diet, and
certain food groups in particular, in the contribution to
the body burden of exposure for our population. Infor-
mation on maternal dietary habits before pregnancy is
collected by means of a food frequency questionnaire
[49], which was validated for dioxin intake through diet
[50]. This questionnaire is administered at the end of
the first trimester. As pregnancy may be a period in
which dietary patterns may change because women may
want to adopt a more healthy lifestyle, women also fill
out a 2-day food diary at the start of the second
trimester.
Exposure to flame retardant chemicals specifically oc-
curs mainly through inhalation and ingestion of contami-
nated house dust. Young children are more exposed to
house dust than adults because of their different body
composition and their specific behavior. Children have a
lower body weight compared to their relative surface area
and therefore have a higher intake of flame retardant che-
micals. Moreover, children explore their environment with
their hands and mouths, performing mouthing behavior,
in which objects are touched with the mouth or objects
are put into the mouth, increasing exposure to contami-
nated dust [51, 52]. Finally, children often play close to the
floor, enhancing direct contact with house dust.
To assess whether dust is a relevant carrier for flame
retardants and if it contributes significantly to exposure
during early childhood, home visits are performed when
the child is 12 months of age. During these visits a saliva
sample is collected from each child, as well as a hand,
back, and mouth wipe to assess how much dust accu-
mulates on the surface of the body and can potentially
be digested or absorbed through the skin. Furthermore
an indoor dust sample from the home is collected. In
these samples flame retardants will be measured. Next
to that, a questionnaire is administered at the start of
the study, and at 6 and 12 months after birth, to inquire
about amongst others housing characteristics, furniture
and characteristics of electronic devices. Information on
cleaning patterns and use of certain products such as
personal care products, but also use of pesticides in the
house and in the garden, is collected through this ques-
tionnaire as well.
Effect biomarkers
Associations with health outcomes will be determined for
each compound individually. However, the compound by
compound approach is not an accurate representation of
the mixture of chemicals we are exposed to, and fails to
take into account that chemicals may interact and may
potentially enhance or diminish the effects they would
have individually. It may therefore be useful to study bio-
markers of effect. These biomarkers should be able to re-
flect complex exposures as well as the accumulation of
exposures over time [53]. They are furthermore able to
relate cause and (health) effect. As we suspect these
Table 1 Measurements in LINC during pregnancy and the first 18 months after birth (Continued)
Month 18 van Wiechen Scheme Second hand smoke exposure
Child behavior (child
behavior checklist)
Mental state, stress (mother)
Crying/sleeping pattern
All measurements are collected from the child, unless mentioned otherwise
Table 2 Anthropometric and behavioral development data collection by research staff (RS), midwives, and youth health care (YHC)
Parameter Recorded by Age child
RS Midwives YHC
Weight X X Birth, 1, 2, 3, 4, 6, 9, 12, 18 months
Length X X Birth, 1, 2, 3, 4, 6, 9, 12, 18 months
Head circumference X X Birth, 6, 12 months
Waist circumference X X Birth, 6, 12 months
Cognitive development X Birth, 1, 2, 3, 4, 6, 9, 12, 18 months
Behavioral development (infant behavior questionnaire, child behavior checklist) X 12, 18 months
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chemicals to be endocrine disruptors, hormone levels will
be included as effect biomarkers.
Cord blood will also be used to determine various
hormone levels, including leptin, adiponectin, ghrelin,
insulin, cortisone, glucagon, insulin-like growth factor
1, and sex hormone-binding globulin. The Dutch National
Institute for Public Health and the Environment is
approached in order to obtain data on thyroid hormones
(total thyroxine) as measured in the neonatal screening
programme.
Sample size
Sample size was calculated for BMI at 12 months of age.
Karmaus et al. [54] observed an increase in BMI of
1.65 kg/m2 in offspring of mothers having maternal
serum levels of DDE of 1.5 – 2.9 μg/L compared to off-
spring of mothers having levels of < 1.5 μg/L DDE.
Smink et al. [36] measured the HCB in cord blood and
related this to BMI at the age of 6 years. Children with
levels higher than 1.03 ng/mL HCB had a BMI which
was 0.95 kg/m2 higher than that of children with levels
lower than 0.46 ng/mL HCB. Karmaus et al. did not
measure DDE in cord blood and they only measured
BMI in the offspring at adult age. Smink et al. on the
other hand did measure BMI in children and determined
exposure to HCB in cord blood. Therefore we consid-
ered a difference in BMI of 1.0 kg/m2 relevant.
Previous measurements of BMI in 12 month old Dutch
children [55], showed that the variation in BMI among
those children is 1.36 kg/m2 (1 SD). Furthermore, based
on data on DDE levels that already have been obtained in
a Belgian cohort [56], we expect that about 30 % of our
sample will have DDE levels of < 1.5 μg/L in cord blood.
In order to determine the required sample size for the
present study, we entered two rows of data in Microsoft
Excel (one with 30 zero’s and one with 70 ones to re-
semble the estimated distribution of DDE levels dichoto-
mised at 1.5 μg/L). Thereafter we simulated BMI scores
to these rows. For the 30 observations, we sampled from
a population with a mean BMI of 17.1 (average BMI of
boys and girls aged 12 months [55]) and SD of 1.36 and
for the 70 observations we sampled from a population
with a mean BMI of 18.1 and SD of 1.36. The mean
BMI of this latter population is the mean BMI in Dutch
boys and girls at the age of 12 months, increased with 1
BMI point. For both groups we selected a sample that
resembled the population parameters and we entered
those data into SPSS 17. In the following step we con-
ducted a regression analysis with the group variable as
independent and BMI scores as outcome. This linear re-
gression analysis resulted in an r2 of 0.11. Finally, this r2
was used to conduct a sample size calculation for mul-
tiple linear regression analysis in STATA 10.0. Assuming
a change in r2 by adding DDE levels to the model of
0.11, an alpha of 0.05, a power of 0.80 and 10 variables
in the final model, the sample size needed is 42. A more
conservative estimate of change in r2 of 0.05 resulted in
a sample size of 88.
The drop-out rate in the study of Karmaus et al. was
55 % [54]. Koletzko et al. [57] followed infants from
birth until they were 2 years of age. The drop-out rate
was approximately 40 % during the course of that study.
To ensure the highest possibility of good statistical
power, the sample size in the present study for this out-
come is set to N = 200. However, experience has indi-
cated that from all participants, only 40 % provides a
complete set of body samples. Moreover, from many
participants, the volume of the cord blood is too low to
be used for measurement of the selected chemicals. For
this reason, we would like to extend the sample size to
500 in order to have samples available for 200 partici-
pants. Data from participants for whom no samples have
been collected, will be used for other purposes than en-
vironmental chemical and health outcome associations.
Currently over 300 mother-child pairs have been in-
cluded, which is comparable to several other studies
conducted on early life environmental chemical expos-
ure and neurodevelopment in children [58–61].
Statistical analyses
For all analyses effect modification of the outcome by
gender will be checked, as the included chemicals dis-
rupt the endocrine system, and in particular steroid
hormones. Linearity of exposure markers and out-
come will furthermore be checked due to suspected
nonmonotonic dose-response associations [62]. Next
to that, various methods will be considered for dealing
with exposure values below the limit of quantification
(LOQ), including replacement by LOQ/√2 [63], and mul-
tiple imputation [64].
In order to quantify the relation between exposure and
BMI at the age of 12 and 18 months, we will use linear
multilevel (mixed) models. These models take into ac-
count the dependency of repeated measures within the
individuals. For each compound a separate model will be
composed for weight, height, BMI, and head circumfer-
ence. Exposure quartiles, time, and gender will be added
to the models as fixed effects and a random effect will
be added for subject. Various covariates, described in
2.5.1, will be tested and included in the model if signifi-
cant (change in β-coefficient > 10 %).
To study the relationship between exposure and behav-
ior at the age of 18 months, linear regression analyses will
be conducted. Both syndrome and DSM-oriented scales
from the CBCL will be used for analysis. Syndrome scales
are: Emotionally Reactive, Anxious/Depressed, Somatic
Complaints, Withdrawn, Attention Problems, Aggressive
Behavior, and Sleep Problems. DSM-oriented scales are:
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Affective Problems, Anxiety Problems, Pervasive De-
velopmental Problems, Attention Deficit/Hyperactivity
Problems, and Oppositional Defiant Problems. The overall
scales ‘Externalizing’ and ‘Internalizing’, and the total score
were also used.
Covariates
Potential covariates were selected based on literature.
Weight and length of both parents are measured by the
midwife at inclusion, approximately 10–12 weeks in
pregnancy. Measurement of maternal weight is repeated
at 36 weeks of pregnancy to determine gestational
weight gain. Gestational age is determined by means of
ultrasound. Birth weight is measured by a midwife or a
nurse and is obtained from registries of the midwives.
Questionnaires are administered at inclusion and the
start of the second trimester to collect information on
education (having a bachelor or master degree, yes or no),
birth date of the mother, parity, and maternal smoking
(yes or no) and alcohol intake during the first trimester
(drinks per week). At inclusion, fish intake (grams per
day) is determined by food frequency questionnaire which
includes both frequencies and portion sizes [49]. One
month after birth another questionnaire is administered
to inquire on the use of medication during pregnancy, in-
cluding folic acid intake (yes or no).
Discussion
Ethics and safety considerations
Conduction of this study will be according to the princi-
ples of the Declaration of Helsinki (version October
22nd, 2008) and in accordance with the Medical Re-
search Involving Human Subjects Act (WMO). This
study was approved by the medical ethics committee of
the VU University Medical Centre.
The target group of this research is infants aged 0 –
18 months. Consent for the infant is given by the
mother, who is specifically required to give consent for
both herself as well as her child. Furthermore it will be
stressed that participants may leave the project at any
time if they desire to do so and that neither withdrawal
nor the decision not to participate will affect the care
provided to them by midwives or youth health care.
The LINC study is a non-invasive study. The majority
of the data will be collected through regular health care
(midwives, obstetricians and youth health care). Further-
more, questionnaires will be administered, cord blood,
placentas, breast milk, urine, saliva, vernix and meco-
nium will be collected. In addition, hand-wipes, mouth-
wipes, and back-wipes will be collected from each child,
and waist circumference and head circumference will
also be measured in children. All these measurements
are non-invasive.
Dissemination
Results will be published in international peer reviewed
journals and multiple doctoral theses, regardless of the
findings of this study. Furthermore they will be presented
at national and international scientific conferences.
Translation of results to society is considered high
priority as this will create knowledge and awareness
amongst various stakeholders. We aim to share study re-
sults with professional groups related to the target popu-
lation involved in the cohort, i.e. pregnant women and
children. These professional groups include midwives,
obstetricians, and pediatricians, but other stakeholders
may be involved as the study progresses. We will fur-
thermore disseminate results to the general public as
well as policy makers.
Strengths and limitations
The LINC study is a prospective birth cohort, which is
one of the main strengths. Data of the children within
the study is already collected very early during preg-
nancy and though current follow-up is planned until the
children are 18 months of age, long-term follow-up is
required to proper study associations with growth and
behavioural development in children. Approval for ex-
tension of follow-up until the children are 48 months of
age has already been given, but it is likely that follow-up
will be extended to later ages. Furthermore a large var-
iety of data is collected, focussing on multiple aspects of
child health including growth, behavior, and nutrition, as
well as factors in the direct environment of the child
such as parental wellbeing, health, lifestyle, and residen-
tial environment.
Biological samples are collected at various time points
to complete the information on health and development
from each child. A broad range of exposures is assessed
within these samples, taking into account already fre-
quently studied compounds such as PCB-153, DDE, and
dioxins, but also relatively new groups of chemicals such
as perfluorinated alkyl acids, phthalates, carbamates, and
pyrethroids. This facilitates comparison with previous
studies but also adds to the body of knowledge on less
frequently studied compounds. Studies which have
assessed such a broad range of environmental chemicals
in a variety of samples from a prospective mother-child
cohort have thus far been few. We will furthermore aim
to look further than the compound-by-compound ap-
proach and to look at chemical mixtures, amongst
others by studying biomarkers of effect.
The population of the LINC study is very homoge-
neous, which is an advantage as associations are less
likely to be confounded by demographic or socio-
economic factors. Extrapolation of results to the general
population or other specific groups should be done with
caution. Another point is that a relatively small number
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of respondents is included in the cohort. About one in
fifteen pregnant women agreed to participation. A large
proportion of the women declined to participate due to
the study duration and the anticipated burden of the
tasks associated with the study during pregnancy and
after birth - periods which were already perceived as
quite intense by most potential participants. However,
as this is a prospective birth cohort, no selections in
study population are made. All women are eligible for
participation, unless they are unable to fill out the
Dutch questionnaires. These cases have thus far been
extremely rare.
Efforts are made to keep drop-out rates as low as
possible, amongst others by regularly sharing results
of the study and translating these to daily life applica-
tions. However, due the duration of the study for
each participant, loss to follow-up is inevitable. Thus
far 67 participants dropped-out, which is approxi-
mately 22 %. This is lower than expected from other
studies, and this percentage of drop-out was taken
into account in the power calculations. For publications
participants included in the study will be compared to
participants who were excluded or dropped-out. Next to
that, the LINC study has been designed in cooperation
with other prospective mother-child cohorts within
Europe, which also focus on early life environmental
chemical exposure. The main reason for doing as such, is
to facilitate cooperation for data-analysis. Through these
common efforts, sufficient statistical power can be achieved
to study the health effects of environmental chemicals.
In conclusion, the LINC study, as a prospective
cohort, will provide insight into the effects of early life
exposure to EDCs on child health and development, in-
cluding childhood obesity and neurodevelopmental dis-
orders. Knowledge on the etiology of these childhood
disorders is valuable as this may enable more effective
prevention and intervention. Our aim is to extend
follow-up of our participants throughout childhood and
hopefully adolescence and adulthood to further study
long-term health effects of environmental exposures.
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